BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27714817)

  • 1. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
    Kaialy W; Bello H; Asare-Addo K; Nokhodchi A
    J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets.
    Adibkia K; Shokri J; Barzegar-Jalali M; Solduzian M; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2014 Jan; 113():10-4. PubMed ID: 24060925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders.
    Shojaee S; Asare-Addo K; Kaialy W; Nokhodchi A; Cumming I
    AAPS PharmSciTech; 2013 Sep; 14(3):1190-8. PubMed ID: 23900884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic aspects of drug loading in liquisolid systems with hydrophilic lipid-based mixtures.
    Vraníková B; Niederquell A; Ditzinger F; Šklubalová Z; Kuentz M
    Int J Pharm; 2020 Mar; 578():119099. PubMed ID: 32006624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique.
    Khanfar M; Sheikh Salem M; Kaddour F
    Pharm Dev Technol; 2014 Feb; 19(1):103-15. PubMed ID: 23347382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fillers and sodium metabisulfite on drug release from aged polyox tablets.
    Shojaee S; Nokhodchi A; Cumming I
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1451-8. PubMed ID: 23962147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.
    Shojaee S; Emami P; Mahmood A; Rowaiye Y; Dukulay A; Kaialy W; Cumming I; Nokhodchi A
    AAPS PharmSciTech; 2015 Dec; 16(6):1281-9. PubMed ID: 25771738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles.
    Elkordy AA; Tan XN; Essa EA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):203-23. PubMed ID: 22960707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.